-+ 0.00%
-+ 0.00%
-+ 0.00%

Wolfe Research Initiates Coverage On BeOne Medicines with Outperform Rating, Announces Price Target of $340

Benzinga·03/27/2026 11:53:54
Listen to the news
Wolfe Research analyst Kalpit Patel initiates coverage on BeOne Medicines (NASDAQ:ONC) with a Outperform rating and announces Price Target of $340.